• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Shan Chikhale, Professor of Pharmaceutical Sciences, School of
Shan Chikhale, Professor of Pharmaceutical Sciences, School of

Multidisciplinary Medication Review Guide
Multidisciplinary Medication Review Guide

...  Consider frailty of the individual, as not all individuals over the age of 65 years old are frail. Consider physiological age to help direct therapy. Drugs that have a long time to benefit may be less appropriate in a frail elderly person than in a vibrant elderly person. ...
FDA-IND Application Guidance
FDA-IND Application Guidance

... 3. The investigation does not involve a route of administration or dosage level or use in a patient population or other factor that significantly increases the risks (or decreases the acceptability of the risks) associated with the use of the drug product 4. The study is conducted in compliance with ...
Speaker`s Notes
Speaker`s Notes

... When provided extra-label use instructions by a veterinarian, you must maintain the altered instructions provided by your veterinarian and strictly follow them. Extra-label drug use can only be recommended by ...
the meaning of medications: another look at compliance
the meaning of medications: another look at compliance

Medication Administration
Medication Administration

Medication Administration
Medication Administration

... end of an inhaler that assists the patient in receiving a higher % of drug with each inhalation • Nebulizer: Aerosolized medication either given by a hand held device or by a face mask (peace pipe) ...
Exhibit B
Exhibit B

... chloride as the tonicity agent, and the new formulation uses mannitol, Novartis asserts that FDA may not approve an ANDA for the discontinued formulation of Sandostatin. Ncavartis asserts that approval of such an ANDA is precluded by FDA's regulation at 21 CF'R 314.94(a)(9)(iii) (May 3, 2002, commen ...
JANUARY Newsletter - Manatee Your Choice
JANUARY Newsletter - Manatee Your Choice

... Through Manatee, generic medications have $5 copays for a 30 day supply at preferred pharmacies while brand medications have $40 copays. Switching between brand and generic medication may include additional cost due to office appointments and lab monitoring. It is not as easy as just switching one f ...
bureau of tenncare - Magellan Health Services || TennCare Portal
bureau of tenncare - Magellan Health Services || TennCare Portal

... PREFERRED DRUG LIST (PDL) FOR TENNCARE EFFECTIVE 4-1-14 TennCare is continuing the process of reviewing all covered drug classes. Changes to the PDL may occur as new classes are reviewed and previously reviewed classes are revisited. As a result of these changes, some medications your patients are n ...
15. Recent Trends in Sustained Release Drug Delivery System
15. Recent Trends in Sustained Release Drug Delivery System

ASHP Technical Assistance Bulletin on Compounding Nonsterile
ASHP Technical Assistance Bulletin on Compounding Nonsterile

... FCC grade (meeting or exceeding requirements defined by the Food Chemicals Codex). Additional professional judgment is especially necessary in cases of chemical substances that have not been approved for any medical use. Particularly in these cases, but also in others as needed, the pharmacist, pres ...
The Top 6 June specials 2015
The Top 6 June specials 2015

... Magnesium-L-aspartate (Magnaspartate®) is the preferred choice for the treatment and prevention of magnesium deficiency when clinically appropriate as it is the only UK licensed oral magnesium preparation If magnesium-L-aspartate (Magnaspartate®) is not effective in raising magnesium levels or if it ...
M P D U
M P D U

... obtain payment for covered outpatient prescription drugs, health care providers submit claims to their Medicare contractors using codes established by CMS, called Healthcare Common Procedure Coding System (HCPCS) codes. 4 In 2010, Medicare and its beneficiaries spent $12 billion for Part B drugs. Pa ...
rav - PHSI
rav - PHSI

rav
rav

... Vasodilators :  Isosorbide dinitrate and hydralazine also used specially in patients who cannot tolerate ACE inhibitors.  Amlodipine and prazosin are other vasodilators can be used in CCF. ...
Pharmaceutical excipients and pediatric formulations
Pharmaceutical excipients and pediatric formulations

... Similarly, distribution of drugs can be severely impacted in pediatric reactions. The interactions thus produced due to drug-excipient, sub-population as the amount of body water is significantly higher excipient-excipient, or excipient-intracellular chemicals can be in neonates (85 percent) as comp ...
Off-label use of medical products in radiation therapy
Off-label use of medical products in radiation therapy

... medical device. The FDA review process may simply involve filing what is known as a Premarket Notification or 510共k兲, named after Section 510共k兲 of the Food, Drug, and Cosmetic Act. It allows the FDA to determine whether the device is equivalent to a predicate device which has already been placed in ...
Predictability of Idiosyncratic Drug Toxicity Risk for Carboxylic Acid
Predictability of Idiosyncratic Drug Toxicity Risk for Carboxylic Acid

... Correlation between the Risk of IDT and the Half-Lives of AGs in KPB. In KPB, although the half-lives of AGs in the safe category were 7.2 h or longer, those in the warning category were 3.2 h or shorter except for mefenamic acid, and those in the withdrawn category were 1.7 h or shorter (Table 2). ...
Formulation and Evaluation of Fenofibrate Tablets Using
Formulation and Evaluation of Fenofibrate Tablets Using

... well as increasing high-density lipoprotein (HDL) levels and reducing triglycerides level. In this study, fenofibrate 160mg tablets were prepared by wet granulation method using sodium lauryl sulfate (SLS) and Povidone k-30 as a binding agents with different concentrations and evaluated for uniformi ...
A Means to Address Regional Variability in Intestinal
A Means to Address Regional Variability in Intestinal

... This series of electrical events originates in the foregut and continues to the terminal ileum in the fasted state, repeating every 2–3 h (16). Feeding sets off a continuous pattern of spike potentials and contractions called postprandial motility. The particular phase during which a dosage form is ...
2006; 15: 618–627 pharmacoepidemiology and drug safety
2006; 15: 618–627 pharmacoepidemiology and drug safety

... For this study, we defined deaths due to drug poisoning as those that NCHS coded to poisoning from ‘drugs, medicaments, or biological substances.’ This definition included deaths due to all types of both licit and illicit drugs. It did not include poisoning from alcohol or tobacco. Deaths involving ...
PUBLIC ASSESSMENT REPORT of the Medicines Evaluation Board
PUBLIC ASSESSMENT REPORT of the Medicines Evaluation Board

... therefore linked to the ‘original’ authorised medicinal product, which is legally allowed once the data protection time of the dossier of the reference product has expired. For this kind of application, it has to be demonstrated that the pharmacokinetic profile of the product is similar to the pharm ...
pharmacy technician ce program - Power
pharmacy technician ce program - Power

... UAN: 0430-0000-15-009-H01-T Credits: 2.0 hours (0.20 ceu) GOAL To improve the pharmacy technician’s ability to locate and utilize appropriate drug information resources in pharmacy practice in order to help the pharmacist respond to questions from consumers and other health care professionals in an ...
Dow Corning Silicones in Pharmaceutical Applications
Dow Corning Silicones in Pharmaceutical Applications

... While the legal controversy regarding silicone gel-filled implants continues in the United States (US), these medical devices are widely available worldwide and are available with some restriction in the US where they have been used since the early 1960’s. The controversy in the 1990’s initially inv ...
< 1 ... 18 19 20 21 22 23 24 25 26 ... 130 >

Pharmaceutical marketing

Pharmaceutical marketing, sometimes called medico-marketing or pharma marketing in some countries, is the business of advertising or otherwise promoting the sale of pharmaceuticals or drugs.Many countries have measures in place to limit advertising by pharmaceutical companies.Pharmaceutical company spending on marketing far exceeds that of its research budget. In Canada, $1.7 billion was spent in 2004 to market drugs to physicians; in the United States, $21 billion was spent in 2002. In 2005, money spent on pharmaceutical marketing in the United States was estimated at $29.9 billion with one estimate as high as $57 billion. When the U.S. numbers are broken down, 56% was free samples, 25% was pharmaceutical sales representative ""detailing"" (promoting drugs directly to) physicians, 12.5% was direct to user advertising, 4% on detailing to hospitals, and 2% on journal ads. There is some evidence that marketing practices can negatively affect both patients and the health care profession.
  • studyres.com © 2026
  • DMCA
  • Privacy
  • Terms
  • Report